Description: The insurance industry recently adopted two significant accounting changes. Good risk management requires a solid understanding of new risks as well as a proper set of controls. Learn how internal audit can help actuaries better understand arising risks and build a more robust control framework.

Description: Dana M. Peterson, chief economist for the Conference Board, has established herself as a visionary, and the go to expert providing insightful analysis and predictions to corporations, associations, and government organizations looking for clarity and foresight into how economic drivers might impact their businesses in the short- and long-term. With over two decades of experience in the field, she serves as the globally recognized think tank’s public face and primary spokesperson on all things related to the economy.

Description: This session will focus on hot topics at an intermediate level for actuaries supporting year-end financial reporting on orange blank. We will discuss responsibilities and considerations when issuing statement of actuarial opinion. We will also discuss capital management for health insurers and important considerations beyond capitalization.

Description: Life insurance with LTC features is exciting business to produce, but the complex for a valuation actuary at year-end. This session will discuss setting morbidity and policyholder behavior assumptions for principles-based reserving and cash flow testing more generally. We will review considerations for GAAP reserving for hybrid products. We will highlight the interaction of assumptions whose risks offset (mortality, morbidity, lapse, and more) and how the valuation actuary may think of these in sensitivity testing and setting prudent estimates. Panelists will draw from the 2022 Academy of Actuaries Combination Product Valuation Practice Note.Finally, we will discuss reserve assumption setting in light of public-private LTC legislation (e.g. Washington Cares), which inspired sales of hybrid life and LTC products in the individual and worksite markets.

Description: "Population Aging, Global Climate Change and Social Security – Sally Shen, Research Associate, Global Risk Institute, John A. Turner, Ph.D., Director, Pension PolicyClimate Change and Mortality Time for Actuaries to Pay Attention – Sam Gutterman. FSA, CERA, FCAS, FCA, HONFIA, MAAA"

Description: Discover an introduction to decomposing differences in life expectancy by age and cause of death. Take a look into demographic techniques that decompose life expectancies at birth and older ages into the portions contributed by later age groups and causes of death-. These have been in existence for some time and provide a convenient device for analyzing mortality change over time as well as differences between sexes, countries, and ethnic groups. The methods will be described and illustrated by spreadsheet examples.

Description: Explore an introduction to Insurtech and a sampling of a few FSAs who have pivoted into Insurtech. You'll hear about their career journeys, how their traditional actuarial backgrounds prepared them for success in Insurtech roles, and about the Insurtech work they're currently doing in life insurance, health insurance, and property & casualty insurance.

Description: Explore insights to non-traditional actuarial roles from a panelist with experiences in data science, finance and entertainment. The panelist will be sharing their perspectives on their non-traditional actuarial role in relation to the actuarial profession.

Description: "Spread pricing is a pricing methodology where pharmacy benefit managers (PBMs) bill a payer one price but reimburses the dispensing pharmacy a lower price for the same prescription drug. PBMs have historically relied on spread pricing as a revenue source. However, a growing number of states are introducing and passing legislation prohibiting spread pricing for Medicaid and commercial clients. In addition, new entrants to the PBM and mail-order pharmacy space are disrupting the market by offering services that promote increased transparency and member satisfaction. Expect updates on recent legislative trends and market disruptions targeted towards increasing PBM drug pricing transparency. By attending this session, you will have a better understanding of how changing legislation and market disruptions may impact current pricing methodologies."

Description: Come explore an in-depth overview of telehealth to set context and navigate the continuing expansion of telehealth and its integration into the healthcare delivery system. You will examine the forces that shape telehealth offerings and expect a view of the possible futures of this evolving modality.